source
- Trump executive order accelerates psychedelic drug development with priority review vouchers, funding and expanded right-to-tryPresident Trump signed an executive order that aims to speed the development and approval of psychedelic medicines. The order directs the FDA to issue priority review vouchers, expands right-to-tr…
- Gene therapy leaders in Rome flag FDA regulatory shifts as key challengeGene therapy manufacturers gathered in Rome to discuss the sector’s outlook in Europe, with the U.S. Food and Drug Administration’s recent actions dominating conversation. Speakers highlighted rec…